DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

SURMOUNT-1

Mounjaro

Without diabetes · 72 weeks · n=2,539

Double-blind, placebo-controlled. Treatment-regimen analysis.

Mean body weight change at 72 weeks
  • Tirzepatide 5 mg−15.0%
  • Tirzepatide 10 mg−19.5%
  • Tirzepatide 15 mg−20.9%
  • Placebo−3.1%
Published paper PubMed abstract NCT04184622

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.